blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1839661

EP1839661 - Pipecolic acid-containing antidiabetic compositions [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.02.2012
Database last updated on 08.10.2024
Most recent event   Tooltip24.02.2012Application deemed to be withdrawnpublished on 28.03.2012  [2012/13]
Applicant(s)For all designated states
Ajinomoto Co., Inc.
15-1, Kyobashi, 1-chome, Chuo-ku
Tokyo / JP
[2007/40]
Inventor(s)01 / Tagaki, Tomo
c/o Ajinomoto Co., Inc. 1-1, Suzuki-cho, Kawasaki-ku
Kawasaki-shi, Kanagawa / JP
02 / Nakano, Takashi
c/o Ajinomoto Co., Inc. 1-1, Suzuki-cho, Kawasaki-ku
Kawasaki-shi, Kanagawa / JP
03 / Ohta, Fumio
c/o Ajinomoto Co., Inc. 1-1, Suzuki-cho, Kawasaki-ku
Kawasaki-shi, Kanagawa / JP
04 / Miyazawa, Yuki
c/o Ajinomoto Co., Inc. 1-1, Suzuki-cho, Kawasaki-ku
Kawasaki-shi, Kanagawa / JP
05 / Satou, Hiroyuki
c/o Ajinomoto Co., Inc. 1-1, Suzuki-cho, Kawasaki-ku
Kawasaki-shi, Kanagawa / JP
 [2007/40]
Representative(s)Nicholls, Kathryn Margaret, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2007/40]Nicholls, Kathryn Margaret, et al
Mewburn Ellis LLP York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date07251317.928.03.2007
[2007/40]
Priority number, dateJP2006009114729.03.2006         Original published format: JP 2006091147
[2007/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1839661
Date:03.10.2007
Language:EN
[2007/40]
Type: A3 Search report 
No.:EP1839661
Date:30.04.2008
[2008/18]
Search report(s)(Supplementary) European search report - dispatched on:EP31.03.2008
ClassificationIPC:A61K31/4453, A61P3/06, A61P3/10, A61P9/10, A61P9/12
[2007/40]
CPC:
A61K31/4453 (EP,US); A61P3/00 (EP); A61P3/04 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P9/10 (EP);
A61P9/12 (EP) (-)
Designated contracting statesDE,   FR,   GB [2009/02]
Former [2007/40]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Pipecolsäurehaltige antidiabetische Zusammensetzungen[2007/40]
English:Pipecolic acid-containing antidiabetic compositions[2007/40]
French:Composition antidiabétiques contenant de l'acide pipécolique[2007/40]
Examination procedure17.04.2007Examination requested  [2007/40]
26.06.2008Despatch of a communication from the examining division (Time limit: M06)
31.10.2008Loss of particular rights, legal effect: designated state(s)
04.12.2008Despatch of communication of loss of particular rights: designated state(s) AT, BE, BG, CH, CY, CZ, DK, EE, ES, FI, GR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR
31.12.2008Reply to a communication from the examining division
25.02.2010Despatch of a communication from the examining division (Time limit: M06)
07.09.2010Reply to a communication from the examining division
01.10.2011Application deemed to be withdrawn, date of legal effect  [2012/13]
07.11.2011Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/13]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  26.06.2008
Fees paidRenewal fee
13.03.2009Renewal fee patent year 03
15.03.2010Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.03.201105   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]JP2002284683  ;
 [Y]US4181663  (HAUGWITZ RUDIGER D [US], et al) [Y] 1-11 * column 1, lines 5-14 * * column 4, lines 35-55 * * example 10 *;
 [Y]GB2070586  (SQUIBB & SONS INC) [Y] 1-11 * page 1, lines 1-5 * * page 4, lines 30-43 ** example 13 *;
 [XY]US4311697  (KRAPCHO JOHN) [XY] 1-11 * column 1, lines 10-61 * * column 9, line 57 - column 10, line 43 * * example 11 *;
 [XY]WO2005047297  (PHENOMIX CORP [US], et al) [XY] 1-11 * page 1, paragraph 1 * * page 118; example 6 * * page 129; compound 68 * * page 96, paragraph 196 *;
 [XY]EP1552834  (FUJISAWA PHARMACEUTICAL CO [JP]) [XY] 1-11 * column 2, paragraphs 5,6 * * column 4, paragraph 14 *;
 [XY]WO2005065675  (PREMACS INTERNAT PTY LTD [AU], et al) [XY] 1-11 * page 1, lines 3-5 * * page 6, line 19 * * page 6, line 26 - page 7, line 4 * * page 7, line 22 - page 8, line 8 * * page 9, lines 3-12 * * page 16, lines 24-31 * * claims 1,3,9 *;
 [XY]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2003, no. 16, Database accession no. 2003-160075, XP002471542 & JP2002284683 A 20021003 (AJINOMOTO KK) [XY] 1-11 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.